Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Study+Type%3A+Interventional%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22
/vufind/Search/Results?lookfor=%22Study+Type%3A+Interventional%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22
Search /vufind/Search2/Results?lookfor=%22Study+Type%3A+Interventional%22&type=Subject&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22
PubPharm (191.797)
1
A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors : A PHASE 1A/B OPEN-LABEL MASTER STUDY OF PF-07799544 AS A SINGLE-AGENT AND IN COMBINATION WITH OTHER TARGETED AGENTS IN PARTICIPANTS WITH ADVANCED SOLID TUMORS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) : A Phase 3, Randomized, Open-Label Study to Evaluate Safety and Efficacy of Epcoritamab in Combination With R-CHOP Compared to R-CHOP in Subjects With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial : Molecular Analysis for Combination Therapy Choice (ComboMATCH)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer : Phase I/Ib Study of AKT Inhibitor Ipatasertib With Chemoradiation for Locally Advanced Head and Neck Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers : A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination With Chemotherapy With or Without Tislelizumab in Subjects With HER2-positive Unresectable Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (GEA)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis : A Randomized, Double-blind, Parallel Group, Placebo-controlled, Multicenter Phase 3 Trial to Evaluate Efficacy, Safety and Tolerability of Ianalumab on Top of Standard-of-care Therapy in Participants With Active Lupus Nephritis (SIRIUS-LN).
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Title: Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST) : Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma : A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine : A Randomized, Double-Blind, Parallel-Group, Active Controlled Trial With Open-Label Safety Extension to Evaluate the Tolerability, Safety, and Efficacy of Atogepant Versus Topiramate in Subjects Requiring Preventive Treatment of Migraine (TEMPLE)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Study in Healthy Men to Test How Well Multiple Doses of BI 1839100 Are Tolerated and How BI 1839100 Influences the Amount of Other Medicines in the Blood : A Phase I Study to Assess Safety, Tolerability, Pharmacokinetics and Effect of Food on Multiple Rising Oral Doses of BI 1839100 (Single-blind, Randomised, Placebo-controlled, Parallel Group Design) and the Effect of Multiple Doses of BI 1839100 on the Single Dose Pharmacokinetics of Cytochrome P450 Substrate (Midazolam), a P Glycoprotein Substrate (Digoxin) and OATP Substrate (Rosuvastatin) Administered Orally (Open-label, Fixed-sequence) in Healthy Male Subjects
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19180]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Recruiting
Medienart
191.797
Aufsätze
191.797
E-Artikel
191.797
E-Ressourcen
Zeitschriftentitel
128.476
WHO International Clinical Trials Registry Plat...
63.321
ClinicalTrials.gov
Thema
191.797
610
Recruitment Status: Recruiting
191.513
Study Type: Interventional
14.636
Phase: Phase 2
9.608
Phase: Phase 3
7.684
Phase: Phase 1
7.464
Phase: Phase 4
3.958
Phase: Phase 2/Phase 3
3.072
Phase: Other
3.070
Phase: New Treatment Measure Clinical Study
2.804
Phase: Phase 1, Phase 2
2.633
Phase: Phase 1/Phase 2
2.102
Neoplasms
2.046
Carcinoma
1.725
Breast Neoplasms
1.384
Syndrome
1.348
Phase: Post-market
1.241
Phase: Early Phase 1
1.228
Lymphoma
1.178
Lung Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
166.224
2020-
25.572
2010-2019
1
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
189.759
Englisch
1.522
Unbestimmt
414
Niederländisch
12
Portugiesisch
10
Dänisch
10
Sanskrit
8
Afrikaans
8
Deutsch
6
Latein
4
Indonesisch
4
Interlingua (International Auxiliary Language A...
4
Norwegisch
4
Slowakisch
2
Corsican
2
Tschechisch
2
Esperanto
2
Frisian
2
Irisch
2
Kinyarwanda
2
Lingala
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...